Page last updated: 2024-12-05

diphenylmethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diphenylmethane is an organic compound with the formula (C6H5)2CH2. It is a colorless solid, soluble in many organic solvents, but insoluble in water. It is a key intermediate in the synthesis of many organic chemicals, including pharmaceuticals, dyes, and pesticides. Diphenylmethane is used as a solvent, a plasticizer, and a stabilizer for plastics. It is also used as a raw material in the production of resins, adhesives, and coatings. Diphenylmethane can be synthesized by the Friedel-Crafts alkylation of benzene with benzyl chloride, using a Lewis acid catalyst, such as aluminum chloride. Diphenylmethane is also a precursor to the triphenylmethane dyes, a class of synthetic dyes that were historically important for their brilliant colors and high tinctorial strength. Diphenylmethane is studied because of its potential applications in various fields, including medicine, materials science, and environmental science. For example, diphenylmethane derivatives have been investigated as potential anti-cancer agents, antioxidants, and antibacterial agents. Diphenylmethane is a useful intermediate in organic chemistry and its derivatives have a variety of potential applications.'

diphenylmethane : A diarylmethane that is methane substituted by two phenyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7580
CHEMBL ID1796022
CHEBI ID38884
MeSH IDM0055418

Synonyms (66)

Synonym
BIDD:ER0257
LS-14188
toluene, .alpha.-phenyl-
wln: r1r
nsc-4708
1,1'-dimethylenebis(benzene)
ditane
benzene,1'-methylenebis-
ditan
101-81-5
benzylbenzene
methane, diphenyl-
nsc4708
benzene, (phenylmethyl)-
benzene, benzyl-
diphenylmethane
diphenylmethyl
ai3-00748
nsc 4708
ai3-28021-x
hsdb 5141
benzyl benzene
diphenyl methane
toluene, alpha-phenyl-
einecs 202-978-6
1,1'-methylenedibenzene
benzene, 1,1'-methylenebis-
inchi=1/c13h12/c1-3-7-12(8-4-1)11-13-9-5-2-6-10-13/h1-10h,11h
diphenylmethane, 99%
diphenylmethane, >=99%
diphenylmethan
1,1'-methylenebisbenzene
CHEBI:38884 ,
alpha-phenyltoluene
(phenylmethyl)benzene
D0896
benzylphenyl
AKOS000120567
A800459
NCGC00248307-01
CHEMBL1796022 ,
dtxsid1041891 ,
NCGC00255045-01
tox21_301147
cas-101-81-5
dtxcid9021891
benzyl-benzene
bdbm50346811
unii-k3e387i0bc
k3e387i0bc ,
methylenedibenzene
FT-0625274
1,1'-methylenebisbenzene [hsdb]
diphenylmethane [mi]
diphenyl methane [inci]
W-108901
mfcd00004781
1,1'-methanediyldibenzene
STL445701
F0001-0052
CS-W009530
Q412882
E75810
SY001825
EN300-21054
1,1'-methylenebis(benzene)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diarylmethaneAny compound containing two aryl groups connected by a single C atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency9.68850.000714.592883.7951AID1259392
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency61.644819.739145.978464.9432AID1159509
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Calmodulin-1Homo sapiens (human)IC50 (µMol)15.02005.17006.81008.0000AID603866
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (31)

Processvia Protein(s)Taxonomy
G2/M transition of mitotic cell cycleCalmodulin-1Homo sapiens (human)
regulation of heart rateCalmodulin-1Homo sapiens (human)
detection of calcium ionCalmodulin-1Homo sapiens (human)
G protein-coupled receptor signaling pathwayCalmodulin-1Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationCalmodulin-1Homo sapiens (human)
negative regulation of peptidyl-threonine phosphorylationCalmodulin-1Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumCalmodulin-1Homo sapiens (human)
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ionCalmodulin-1Homo sapiens (human)
autophagosome membrane dockingCalmodulin-1Homo sapiens (human)
substantia nigra developmentCalmodulin-1Homo sapiens (human)
positive regulation of protein autophosphorylationCalmodulin-1Homo sapiens (human)
regulation of cytokinesisCalmodulin-1Homo sapiens (human)
positive regulation of phosphoprotein phosphatase activityCalmodulin-1Homo sapiens (human)
positive regulation of protein dephosphorylationCalmodulin-1Homo sapiens (human)
cellular response to interferon-betaCalmodulin-1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATCalmodulin-1Homo sapiens (human)
regulation of calcium-mediated signalingCalmodulin-1Homo sapiens (human)
positive regulation of cyclic-nucleotide phosphodiesterase activityCalmodulin-1Homo sapiens (human)
response to calcium ionCalmodulin-1Homo sapiens (human)
regulation of cardiac muscle contractionCalmodulin-1Homo sapiens (human)
regulation of ryanodine-sensitive calcium-release channel activityCalmodulin-1Homo sapiens (human)
negative regulation of ryanodine-sensitive calcium-release channel activityCalmodulin-1Homo sapiens (human)
positive regulation of ryanodine-sensitive calcium-release channel activityCalmodulin-1Homo sapiens (human)
cellular response to type II interferonCalmodulin-1Homo sapiens (human)
positive regulation of protein serine/threonine kinase activityCalmodulin-1Homo sapiens (human)
regulation of cardiac muscle cell action potentialCalmodulin-1Homo sapiens (human)
organelle localization by membrane tetheringCalmodulin-1Homo sapiens (human)
negative regulation of high voltage-gated calcium channel activityCalmodulin-1Homo sapiens (human)
regulation of cell communication by electrical coupling involved in cardiac conductionCalmodulin-1Homo sapiens (human)
negative regulation of calcium ion export across plasma membraneCalmodulin-1Homo sapiens (human)
mitochondrion-endoplasmic reticulum membrane tetheringCalmodulin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
calcium ion bindingCalmodulin-1Homo sapiens (human)
protein bindingCalmodulin-1Homo sapiens (human)
adenylate cyclase activator activityCalmodulin-1Homo sapiens (human)
calcium channel inhibitor activityCalmodulin-1Homo sapiens (human)
protein kinase bindingCalmodulin-1Homo sapiens (human)
titin bindingCalmodulin-1Homo sapiens (human)
protein serine/threonine kinase activator activityCalmodulin-1Homo sapiens (human)
transmembrane transporter bindingCalmodulin-1Homo sapiens (human)
calcium-dependent protein bindingCalmodulin-1Homo sapiens (human)
protein phosphatase activator activityCalmodulin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
spindle poleCalmodulin-1Homo sapiens (human)
extracellular regionCalmodulin-1Homo sapiens (human)
nucleusCalmodulin-1Homo sapiens (human)
nucleoplasmCalmodulin-1Homo sapiens (human)
cytoplasmCalmodulin-1Homo sapiens (human)
centrosomeCalmodulin-1Homo sapiens (human)
cytosolCalmodulin-1Homo sapiens (human)
spindle microtubuleCalmodulin-1Homo sapiens (human)
plasma membraneCalmodulin-1Homo sapiens (human)
sarcomereCalmodulin-1Homo sapiens (human)
vesicleCalmodulin-1Homo sapiens (human)
myelin sheathCalmodulin-1Homo sapiens (human)
sperm midpieceCalmodulin-1Homo sapiens (human)
voltage-gated potassium channel complexCalmodulin-1Homo sapiens (human)
protein-containing complexCalmodulin-1Homo sapiens (human)
calcium channel complexCalmodulin-1Homo sapiens (human)
catalytic complexCalmodulin-1Homo sapiens (human)
cytoplasmCalmodulin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID603867Binding affinity to human Calmodulin M124C mutant assessed as extrinsic fluorescence quenching in phosphate buffer at pH 5.1 by mBBr fluorescence assay2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis, biological evaluation, and docking studies of gigantol analogs as calmodulin inhibitors.
AID603866Inhibition of Calmodulin-dependent PDE1 activity assessed as inorganic phosphate release after 30 min2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis, biological evaluation, and docking studies of gigantol analogs as calmodulin inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (31.94)18.7374
1990's5 (6.94)18.2507
2000's15 (20.83)29.6817
2010's26 (36.11)24.3611
2020's3 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.75 (24.57)
Research Supply Index4.33 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index98.62 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (60.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.35%)5.53%
Reviews1 (1.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other72 (97.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]